The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Fund Price: $11.71 (as at December 24, 2014)  1-day chg: $.0573 0.49%  YTD: 28.34%

Returns as at November 30, 2014

  Fund Group Avg Index*
1 Month 5.60% 3.39% 4.07%
3 Months 10.78% 6.21% 9.16%
6 Months 18.94% 11.00% 13.71%
1 Year 32.86% 19.03% 25.48%
2 Year Avg 37.38% 27.41% 32.09%
3 Year Avg 24.91% 20.97% 25.43%
4 Year Avg 18.77% 16.03% 20.58%
5 Year Avg 18.65% 14.29% 17.67%
10 Year Avg 6.83% 5.19% 7.63%
15 Year Avg -1.12% 1.59% 2.89%
20 Year Avg - 5.80% 8.93%
Since Inception 4.21% - -
 
2013 49.09% 38.66% 41.53%
2012 7.22% 10.31% 13.48%
2011 -3.13% -1.52% 4.41%
 
3 year risk 11.69 8.87 6.85
3 year beta 1.26 1.03 1.00

*S&P 500 Composite Total Return Idx($CA)

Growth of $10,000

This graph shows how a $10,000 investment in this fund would have changed in value compared with the S&P 500 Composite Total Return Idx($CA).

Risk Measures as at November 30, 2014

Best/Worst 12 months (since inception)
Best (ending Feb 00): 138.27 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
Worst (ending Sep 01): -61.90 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
Volatility meter (Based on 3 year standard deviation from GlobeInvestor.com)
Low VOLATILITY METER: 12 High

Fund Objectives

To provide long-term capital growth. The fund invests primarily in equity securities of U.S. companies whose businesses relate to life sciences and technology and are expected to benefit from scientific and technological advances.

Fund Facts

Fund Sponsor: RBC Global Asset Management Inc.
Managed by: RBC Global Asset Management Inc.
Fund Type: MF Trust
Inception Date: July 1995
Asset Class: U.S. Equity
Quartile Rank: 1 (3YR ending November 30, 2014)
Total Assets: $145.3 million
Mgmt Exp. Ratio (MER): 2.20%
Management Fee: 1.85%
Load Type: No Load
Globe 5-Star Rating:
RRSP Eligible:
Canadian
Min. Invest (initial):
$500
Subsequent:
$25
Min. Invest (initial RRSP):
$500
Subsequent RRSP:
$25
Closed:
No
Restricted:
No
Restriction:
 
 

Asset Allocation December 31, 2013

Equity Sector Weightings December 31, 2013

Fund Geography December 31, 2013

Top Holdings as at December 31, 2013

Symbol Company Name Sector Geographic
Area
Asset
Type
% of
Total Assets
  Performance as at December 24, 2014
1 Year Performance (%)
AAPL-Q Apple Electrical & Electronic United States Stock 4.96   41.5 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
GOOG-Q Google Computer Software & Processing United States Stock 3.85   - bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
GILD-Q Gilead Sciences Biotechnology & Pharmaceuticals United States Stock 3.81   24.72 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
MSFT-Q Microsoft Computer Software & Processing United States Stock 2.49   27.88 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
HPQ-N Hewlett-Packard Co. Electrical & Electronic United States Stock 2.14   43.77 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
CELG-Q Celgene Corp. Biotechnology & Pharmaceuticals United States Stock 1.97   34.03 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
STX-Q Seagate Technology Computer Software & Processing Ireland Stock 1.6   22.74 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
ABC-N AmerisourceBergen Wholesale Distributors United States Stock 1.52   30.17 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
INCY-Q Incyte Corporation Biotechnology & Pharmaceuticals United States Stock 1.52   45.8 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)

Portfolio Manager(s)

Ray Mawhinney

RBC Global Asset Management Inc.

Start Date: September, 1999

Fund Return: -0.16%

Ray graduated from the University of Manitoba with a Bachelor of Commerce degree in honours Finance and is a member of the Financial Analysts Federation. As Chair of the RBC Asset Management Inc. (RBC AM) U.S. Equity committee, Ray and his team of experts are responsible for managing the U.S. equity investment activities. Ray is also a member of our Equity Advisory Team.

Also manages:RBC Global Technology Series A, RBC North American Growth Fund, RBC U.S. Eq Currency Neutral Fund, RBC U.S. Equity Fund, RBC U.S. Mid-Cap Eq Currency Neu Fd, RBC U.S. Mid-Cap Equity Fund

View fund manager performance report

Cameron Scrivens

RBC Global Asset Management Inc.

Start Date: October, 2007

Fund Return: 9.34%

Cameron is a member of the RBC Asset Management Inc.'s U.S. Equity Committee. He co-manages the RBC Life Science & Technology Fund, the RBC Global Technology Fund and the RBC Global Health Sciences Fund. Cameron began his career working for accounting firm Ernst & Young in Toronto before moving to the investment industry in 1993 with Carson Group in New York, where he was a health-care analyst. In 1997 he joined AGF Management in Toronto, where he advanced to Vice President and Portfolio Manager responsible for a range of U.S. and global mandates. Cameron joined RBC Asset Management in 2007. Cameron holds a bachelor's degree in philosophy from the University of Western Ontario and an MBA in accounting from the University of Toronto.

Also manages:RBC Global Technology Series A

View fund manager performance report